Lip and oral cavity carcinoma
MONDO:0023644A carcinoma arising in the lip or oral cavity. Most oral cavity carcinomas are squamous cell carcinomas of the tongue, buccal mucosa, or gums. Less frequent morphologic variants include mucoepidermoid carcinoma and adenocarcinoma. Lip carcinomas are usually basal cell or squamous cell carcinomas.
Also known as: lip and oral cavity cancer, lip and oral cavity carcinoma, oral cancer, oral carcinoma
3093 clinical trials for this condition and its sub-types, 96 tagged with Lip and oral cavity carcinoma itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Part of
Sub-types of Lip and oral cavity carcinoma
-
Oral cavity carcinoma 16 trials · 202 incl. sub-types
9 sub-types
- Oral cavity squamous cell carcinoma 141 trials · 156 incl. sub-types Sub-types →
- Salivary gland carcinoma 26 trials · 36 incl. sub-types Sub-types →
- Oral cavity carcinoma in situ 5 trials Sub-types →
- Tongue carcinoma 4 trials
- Carcinoma of lip 0 trials · 2 incl. sub-types Sub-types →
- Carcinoma of hard palate 1 trial
- Carcinoma of soft palate 1 trial
- Intraoral basal cell carcinoma 0 trials
- Oral cavity mucoepidermoid carcinoma 0 trials Sub-types →
-
Lip and oral cavity squamous cell carcinoma 21 trials · 159 incl. sub-types
1 sub-type
- Oral cavity squamous cell carcinoma 141 trials · 156 incl. sub-types Sub-types →
Most studied deeper sub-types
-
New cocktail of cancer drugs tested in desperate cases
Disease control Stopped earlyThis early-phase trial tested combinations of the drugs bevacizumab and temsirolimus, sometimes with valproic acid or cetuximab, in 154 people with advanced cancers or certain non-cancerous but progressive diseases. The main goal was to find safe doses and look for any signs that…
Phase 1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
Immune cell therapy tested for tough childhood cancers
Disease control Stopped earlyThis early-phase study tested a treatment using donated natural killer (NK) cells from cord blood, combined with chemotherapy, for children and young adults with solid tumors that returned or didn't respond to standard care. The goal was to find the safest dose and check for side…
Phase 1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
Glow-in-the-Dark dye could help surgeons spot hidden oral cancer cells
Diagnosis Stopped earlyThis study tested a dye called tozuleristide that makes oral cancer cells glow under special light during surgery. The goal was to help surgeons see and remove all cancer while sparing healthy tissue. The trial included 8 adults with oral cavity cancer or high-grade dysplasia. Th…
Phase 1/2 • Sponsor: University of Washington • Aim: Diagnosis
Last updated Sep 18, 2026 00:00 UTC
-
Inhaled cancer drug tested in smokers – early study halted
Knowledge-focused Stopped earlyThis early-stage study tested whether inhaling the cancer drug afatinib works as well as taking it by mouth. Four healthy adult smokers received both forms in separate sessions to compare drug levels in the blood and lungs. The study was terminated early, so the findings are limi…
Phase 1 • Sponsor: Petrov, Andrey • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:00 UTC